NYSE
233.40USD
-1.63 (-0.69%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
38.4B
P/E
—
EPS
—
Beta
1.20
52W range
154.5-251.36
Day range
230.83–238.49
Open
237.17
Prev close
235.02
Volume
1.3M
Avg volume
1.7M
Dividend
0.00
IPO
2013-05-09
https://www.fool.com/coverage/filings/2026/08/02/an-iqvia-insider-just-sold-over-usd1-million-in-stock-here-s-what-long-term-investors-should-know/ · 8/2/2026+0.60
https://www.fool.com/coverage/filings/2026/08/02/an-iqvia-ceo-sold-usd26-1-million-as-bookings-hit-a-record-usd3-15-billion/ · 8/2/2026+0.60
https://www.zacks.com/stock/news/2953351/iqv-vs-pen-which-stock-is-the-better-value-option?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_3-2953351 · 7/14/2026+0.80
https://www.marketbeat.com/instant-alerts/iqvia-q1-earnings-call-highlights-2026-05-10/ · 5/11/2026+0.90
https://seekingalpha.com/article/4899007-artisan-value-fund-q1-2026-portfolio-activity · 5/6/2026+0.60
https://www.zacks.com/stock/news/2915161/iqv-q1-earnings-beat-on-commercial-solutions-strength?cid=CS-STOCKNEWSAPI-FT-analyst_blog|earnings_article-2915161 · 5/5/2026+0.80
https://www.defenseworld.net/2026/04/25/calamos-wealth-management-llc-invests-11-93-million-in-iqvia-holdings-inc-iqv.html · 4/25/2026+0.30
https://seekingalpha.com/article/4880104-iqvia-holdings-inc-iqv-presents-at-leerink-global-healthcare-conference-2026-transcript · 3/9/2026+0.00
https://www.defenseworld.net/2026/02/22/edentree-asset-management-ltd-buys-shares-of-38800-iqvia-holdings-inc-iqv.html · 2/22/2026+0.30
https://www.defenseworld.net/2026/02/21/amg-national-trust-bank-invests-3-71-million-in-iqvia-holdings-inc-iqv.html · 2/21/2026+0.20
https://www.zacks.com/stock/news/2868751/is-the-options-market-predicting-a-spike-in-iqvia-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|options-2868751 · 2/13/2026-0.60
https://www.defenseworld.net/2026/02/08/iqvia-q4-earnings-call-highlights.html · 2/8/2026+0.80
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works